Download presentation
Presentation is loading. Please wait.
1
Volume 60, Issue 2, Pages 231-238 (August 2011)
Long-term Follow-up of Bladder Cancer Patients with Disseminated Tumour Cells in Bone Marrow Margitta Retz, Jens Rotering, Roman Nawroth, Alexander Buchner, Michael Stöckle, Juergen E. Gschwend, Jan Lehmann European Urology Volume 60, Issue 2, Pages (August 2011) DOI: /j.eururo Copyright © Terms and Conditions
2
Fig. 1 (a) Progression-free survival, (b) tumour-specific survival, and (c) overall survival depending on cytokeratin-20. PFS=progression-free survival; CK20=cytokeratin-20; TSS=tumour-specific survival; OS=overall survival. European Urology , DOI: ( /j.eururo ) Copyright © Terms and Conditions
3
Fig. 2 (a) Progression-free survival, tumour-specific survival, and overall survival stratified by cytokeratin-20 status in bone marrow samples and lymph node involvement. PFS=progression-free survival; CK20=cytokeratin-20; TSS=tumour-specific survival; OS=overall survival. European Urology , DOI: ( /j.eururo ) Copyright © Terms and Conditions
Similar presentations
© 2024 SlidePlayer.com. Inc.
All rights reserved.